Long-term treatment with transcranial pulsed electromagnetic fields improves movement speed and elevates cerebrospinal erythropoietin in Parkinson's disease

PLoS One. 2021 Apr 28;16(4):e0248800. doi: 10.1371/journal.pone.0248800. eCollection 2021.

Abstract

Background: Parkinson's disease is characterized by motor dysfunctions including bradykinesia. In a recent study, eight weeks of daily transcranial stimulation with bipolar pulsed electromagnetic fields improved functional rate of force development and decreased inter-hand tremor coherence in patients with mild Parkinson's disease.

Objective: To investigate the effect of long-term treatment with transcranial bipolar pulsed electromagnetic fields on motor performance in terms of movement speed and on neurotrophic and angiogenic factors.

Methods: Patients diagnosed with idiopathic Parkinson's disease had either daily 30-min treatment with bipolar (±50 V) transcranial pulsed electromagnetic stimulation (squared pulses, 3ms duration) for three eight-week periods separated by one-week pauses (T-PEMF group) (n = 16) or were included in a PD-control group (n = 8). Movement speed was assessed in a six-cycle sit-to-stand task performed on a force plate. Cerebrospinal fluid and venous blood were collected and analyzed for erythropoietin and vascular endothelial growth factor.

Results: Major significant improvement of movement speed compared to the natural development of the disease was found (p = 0.001). Thus, task completion time decreased gradually during the treatment period from 10.10s to 8.23s (p<0.001). The untreated PD-control group did not change (p = 0.458). The treated group did not differ statistically from that of a healthy age matched reference group at completion of treatment. Erythropoietin concentration in the cerebrospinal fluid also increased significantly in the treated group (p = 0.012).

Conclusion: Long-term treatment with transcranial bipolar pulsed electromagnetic fields increased movement speed markedly and elevated erythropoietin levels. We hypothesize that treatment with transcranial bipolar pulsed electromagnetic fields improved functional performance by increasing dopamine levels in the brain, possibly through erythropoietin induced neural repair and/or protection of dopaminergic neurons.

Publication types

  • Clinical Trial
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Electromagnetic Fields*
  • Erythropoietin / cerebrospinal fluid*
  • Female
  • Humans
  • Magnetic Field Therapy*
  • Male
  • Middle Aged
  • Movement*
  • Parkinson Disease* / cerebrospinal fluid
  • Parkinson Disease* / physiopathology
  • Parkinson Disease* / therapy
  • Prospective Studies

Substances

  • EPO protein, human
  • Erythropoietin

Grants and funding

The research group received funding from The Jascha Foundation, Denmark; Den A.P. Møllerske Støttefond, Copenhagen, Denmark; and Grosserer L.F. Foghts Foundation, Charlottenlund, Denmark. The authors report no competing interest. Thus, the funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.